Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15486769rdf:typepubmed:Citationlld:pubmed
pubmed-article:15486769lifeskim:mentionsumls-concept:C0034493lld:lifeskim
pubmed-article:15486769lifeskim:mentionsumls-concept:C0009813lld:lifeskim
pubmed-article:15486769lifeskim:mentionsumls-concept:C0035301lld:lifeskim
pubmed-article:15486769lifeskim:mentionsumls-concept:C1760025lld:lifeskim
pubmed-article:15486769lifeskim:mentionsumls-concept:C0003364lld:lifeskim
pubmed-article:15486769lifeskim:mentionsumls-concept:C1261287lld:lifeskim
pubmed-article:15486769lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:15486769lifeskim:mentionsumls-concept:C0597128lld:lifeskim
pubmed-article:15486769lifeskim:mentionsumls-concept:C1720298lld:lifeskim
pubmed-article:15486769lifeskim:mentionsumls-concept:C2684089lld:lifeskim
pubmed-article:15486769lifeskim:mentionsumls-concept:C0772213lld:lifeskim
pubmed-article:15486769pubmed:issue5lld:pubmed
pubmed-article:15486769pubmed:dateCreated2004-10-15lld:pubmed
pubmed-article:15486769pubmed:abstractTextTo compare the inhibitory effect of topically instilled bunazosin hydrochloride (bunazosin), a selective alpha(1)-adrenoceptor antagonist, on the endothelin (ET)-1-induced vasoconstriction in rabbit retinal arteries with the effects of other ocular hypotensive drugs.lld:pubmed
pubmed-article:15486769pubmed:languageenglld:pubmed
pubmed-article:15486769pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15486769pubmed:citationSubsetIMlld:pubmed
pubmed-article:15486769pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15486769pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15486769pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15486769pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15486769pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15486769pubmed:statusMEDLINElld:pubmed
pubmed-article:15486769pubmed:issn0021-5155lld:pubmed
pubmed-article:15486769pubmed:authorpubmed-author:IchikawaMasak...lld:pubmed
pubmed-article:15486769pubmed:authorpubmed-author:SummersLinda...lld:pubmed
pubmed-article:15486769pubmed:authorpubmed-author:OkadaYujiYlld:pubmed
pubmed-article:15486769pubmed:authorpubmed-author:IshiiKiyoshiKlld:pubmed
pubmed-article:15486769pubmed:issnTypePrintlld:pubmed
pubmed-article:15486769pubmed:volume48lld:pubmed
pubmed-article:15486769pubmed:ownerNLMlld:pubmed
pubmed-article:15486769pubmed:authorsCompleteYlld:pubmed
pubmed-article:15486769pubmed:pagination465-9lld:pubmed
pubmed-article:15486769pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:15486769pubmed:meshHeadingpubmed-meshheading:15486769...lld:pubmed
pubmed-article:15486769pubmed:meshHeadingpubmed-meshheading:15486769...lld:pubmed
pubmed-article:15486769pubmed:meshHeadingpubmed-meshheading:15486769...lld:pubmed
pubmed-article:15486769pubmed:meshHeadingpubmed-meshheading:15486769...lld:pubmed
pubmed-article:15486769pubmed:meshHeadingpubmed-meshheading:15486769...lld:pubmed
pubmed-article:15486769pubmed:meshHeadingpubmed-meshheading:15486769...lld:pubmed
pubmed-article:15486769pubmed:meshHeadingpubmed-meshheading:15486769...lld:pubmed
pubmed-article:15486769pubmed:meshHeadingpubmed-meshheading:15486769...lld:pubmed
pubmed-article:15486769pubmed:meshHeadingpubmed-meshheading:15486769...lld:pubmed
pubmed-article:15486769pubmed:meshHeadingpubmed-meshheading:15486769...lld:pubmed
pubmed-article:15486769pubmed:articleTitleEffects of topically instilled bunazosin hydrochloride and other ocular hypotensive drugs on endothelin-1-induced constriction in rabbit retinal arteries.lld:pubmed
pubmed-article:15486769pubmed:affiliationResearch and Development Center, Santen Pharmaceutical Company, Ltd., Nara, Ikoma 630-0101, Japan. yuji.okada@santen.co.jp.lld:pubmed
pubmed-article:15486769pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15486769pubmed:publicationTypeComparative Studylld:pubmed